EXECUTION COPY Page
EXECUTION COPY |
Exhibit 10.19 BY AND AMONG AFBS, INC., THERICS, LLC AND XXXXXXX X. XXXXXX
DATED AS OF JUNE 30, 2005 |
TABLE OF CONTENTS |
i |
4.4 | Employee Matters. | 13 | ||
4.5 | Transfer Taxes. | 13 | ||
4.6 | Income Tax Treatment of Transactions. | 13 | ||
4.7 | Put Right. | 13 | ||
ARTICLE V | SURVIVAL OF REPRESENTATIONS AND WARRANTIES; INDEMNIFICATION |
14 | ||
5.1 | Survival of Representations and Warranties. | 14 | ||
5.2 | Indemnification. | 15 | ||
5.3 | Third-Party Claim Indemnification Procedures. | 16 | ||
5.4 | Exclusive Remedy. | 17 | ||
5.5 | Allocation of Adjusted Annual License Maintenance Fee. | 17 | ||
5.6 | Delivery of Certain Information. | 17 | ||
ARTICLE VI | MISCELLANEOUS PROVISIONS | 17 | ||
6.1 | Notices. | 17 | ||
6.2 | Amendment. | 18 | ||
6.3 | Entire Agreement. | 18 | ||
6.4 | Waiver. | 18 | ||
6.5 | Third-Party Beneficiaries. | 19 | ||
6.6 | No Assignment; Binding Effect. | 19 | ||
6.7 | Headings. | 19 | ||
6.8 | Invalid Provisions. | 19 | ||
6.9 | Governing Law. | 19 | ||
6.10 | WAIVER OF TRIAL BY JURY. | 19 | ||
6.11 | Construction. | 19 | ||
6.12 | Counterparts. | 20 | ||
6.13 | Specific Performance. | 20 | ||
ARTICLE VII | DEFINITIONS | 20 | ||
7.1 | Definitions. | 20 | ||
7.2 | Construction. | 24 | ||
EXHIBITS | |
Exhibit A | Transfer Agreement |
Exhibit B | Operating Agreement |
Exhibit C | Sublease Agreement |
Exhibit D | IP Transfer Agreement |
Exhibit E | Payment Agreement |
ii |
SCHEDULES | |
Schedule 2.3 | No Violation or Conflict |
Schedule 2.5 | No Litigation |
Schedule 2.6 | Contracts |
Schedule 2.7 | Condition of Equipment |
Schedule 2.10 | Intellectual Property |
Schedule 3.4 | No Litigation |
Schedule 3.5 | Financial Statements |
Schedule 3.6 | Compliance with Law |
Schedule 3.7 | Taxes |
Schedule 3.8 | Affiliated Transactions |
Schedule 3.9 | TS Intellectual Property |
Schedule 3.10 | No Material Adverse Change |
Schedule 3.11 | Title; Capitalization |
Schedule 4.4 | Employee Matters |
iii |
UNIT PURCHASE AGREEMENT |
This UNIT PURCHASE AGREEMENT, effective as of June 30, 2005, is made by and among AFBS, INC., a Virginia corporation (f/k/a “Therics, Inc.”) (“AFBS”), THERICS, LLC, an Ohio limited liability company, (“Therics”) and XXXXXXX X. XXXXXX, a resident of the State of Ohio (“RRT”). RECITALS WHEREAS, pursuant to the terms of the Transfer Agreement dated June 30, 2005, by and between AFBS and Therics, and attached hereto as Exhibit A (the “Transfer Agreement”), AFBS has contributed, conveyed, transferred, assigned and delivered to Therics, and Therics has accepted and assumed from AFBS, the Contributed Assets in exchange for 1,000,000 common units of Therics, representing 100% of the membership interest of Therics. WHEREAS, RRT wishes to purchase and acquire from AFBS, and AFBS wishes to transfer and sell to RRT, 825,000 of its outstanding common units (the “Purchased Units”), representing 82.5% of the membership interest of Therics, in exchange for 36,411.305 class A units (the “TS Interest”) of Theken Spine, LLC, an Ohio limited liability company (“TS”), representing 3.5% of the outstanding membership interest of TS. WHEREAS, simultaneously with the execution of this Agreement, (i) RRT and AFBS are executing and delivering the Operating Agreement of Therics in the form attached hereto as Exhibit B (the “Operating Agreement”), (ii) AFBS and Therics are executing and delivering the Sublease in the form attached hereto as Exhibit C (the “Sublease”), and (iii) AFBS will execute and deliver all documents necessary for it to become a member of TS and a party to the TS Operating Agreement, including, without limitation, a counterpart signature page and/or an instrument of accession. WHEREAS, pursuant to terms of the Intellectual Property Transfer Agreement to be entered into by and between AFBS and Therics immediately following the Closing in the form attached hereto as Exhibit D (the “IP Transfer Agreement”), AFBS will sell, convey, transfer, assign and deliver to Therics, and Therics will purchase, accept and assume from AFBS, the IP Assets in exchange for the rights and benefits provided under the Payment Agreement to be entered into by and between AFBS and Therics immediately following the Closing in the form attached hereto as Exhibit E (the “Payment Agreement”). WHEREAS, Therics and TS will enter into a mutually agreeable Distribution Agreement (the “Distribution Agreement”) following the Closing. AGREEMENT NOW, THEREFORE, in consideration of the Recitals, covenants, representations and warranties set forth herein, intending to be legally bound hereby, the parties agree as follows: |
ARTICLE I 1.1 Agreement To Sell and Purchase Units. Subject to the terms and conditions hereof, at the Closing, AFBS will sell, assign and transfer to RRT, and RRT will purchase from AFBS, the Purchased Units free and clear of all Liens, and, in consideration therefor, RRT shall sell, assign and transfer to AFBS, and AFBS will purchase from RRT, the TS Interest free and clear of all Liens. The parties hereto agree that the fair market value of the Purchased Units and of the TS Interest each is $800,000. 1.2 Closing, Delivery And Payment. (a) Closing. The closing of the transactions contemplated hereby (the “Closing”) shall take place immediately upon execution of this Agreement on the date hereof at 11:58 p.m. (Eastern Daylight Time) (the “Closing Date”) at the offices of Hunton & Xxxxxxxx LLP located in Richmond, Virginia at 000 Xxxx Xxxx Xxxxxx. (b) Delivery. At the Closing, (i) AFBS will deliver to RRT certificate(s) representing the Purchased Units, against delivery of instruments of transfer duly executed and endorsed in blank, (ii) RRT will deliver to AFBS certificate(s) representing the TS Interest, against delivery of instruments of transfer duly executed and endorsed in blank, (iii) RRT and AFBS will execute and deliver the Operating Agreement, (iv) AFBS and Therics will execute and deliver the Sublease, and (v) AFBS will execute and deliver all documents necessary for it to become a member of TS and a party to the T S Operating Agreement, including, without limitation, a counterpart signature page and/or an instrument of accession. ARTICLE II AFBS represents and warrants to Therics and RRT at the Closing as follows: 2.1 Organization of AFBS and Therics. (a) AFBS. AFBS is a corporation duly incorporated, validly existing and in good standing under the Laws of the Commonwealth of Virginia. (b) Therics. Therics is a limited liability company duly organized, validly existing and in good standing under the Laws of the State of Ohio and a wholly owned subsidiary of AFBS. Prior to the entering into of this Agreement, the Transfer Agreement and the IP Transfer Agreement, Therics had no assets or liabilities and had no business operations or relations of any kind. 2.2 Authority; Enforceability. The execution and delivery by AFBS of this Agreement and the Ancillary Agreements to which it is a party and the consummation by AFBS of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary corporate action of AFBS. AFBS has full power and authority to execute and deliver this Agreement and the Ancillary Agreements to which it is a party, to perform its obligations |
2 |
3 |
4 |
5 |
investigator, former investigator, or any other person may claim rights to any of inventions covered by the Intellectual Property. (e) AFBS has the full and proper legal right, capacity, ability, and authority to grant the rights in the Intellectual Property granted in the IP Transfer Agreement, and except with respect to rights in the Assumed IP Contracts, does not hold or own any other rights to technology, trade secrets, know-how, inventions, trademarks, trademark applications, trademark registrations, copyrights, copyright applications, copyright registrations, patent applications, or patents (1) necessary or useful to the full enjoyment and exploitation of the Intellectual Property or (2) otherwise used in connection with the Business. (f) No patent or patent application within the Intellectual Property is the subject of any pending interference, opposition, cancellation, protest, reexamination, or other challenge or adversarial proceeding. (g) Except as set forth on Schedule 2.10, no court orders, judgments, or decrees exist that impair or restrict the use, scope, validity, or enforceability of the Intellectual Property and no action, suit, inquiry, proceeding, or investigation is currently pending or threatened before any court, administrative agency, or other governmental body in which such use, scope, validity, or enforceability is being challenged, either directly or indirectly. (h) To the Knowledge of AFBS, no patents in the Intellectual Property are invalid or unenforceable, and to the Knowledge of AFBS, there are no facts from which it can be inferred that any of the patents in the Intellectual Property are invalid or unenforceable. (i) The patent set forth in Schedule 2.5 and any patent resulting from the reexamination proceeding set forth in Schedule 2.5 will not materially adversely impact the scope, validity, or enforceability of any patent rights in the Intellectual Property or the Assumed IP Contracts that are commercially used in the Business. (j) The patents or applications mentioned, listed, or referenced in Schedule 2.10 and any assignment or ownership disputes related thereto that arise either before or after the Effective Time will not materially adversely impact the scope, validity, or enforceability of the Intellectual Property or the Assumed IP Contracts and will not cause Therics to be in breach of any contract, assignment, agreement, or understanding of any kind. (k) To the Knowledge of AFBS, no trademark registrations in the Intellectual Property are invalid or unenforceable, and to the Knowledge of AFBS, there are no facts from which it can be inferred that any of the trademark registrations in the Intellectual Property are invalid or unenforceable. (l) To the Knowledge of AFBS, no pending trademark applications in the Intellectual Property were filed under circumstances that would render any resulting registration invalid or unenforceable, and to the Knowledge of AFBS, there are no facts from which it can be inferred that any registration resulting from any pending trademark application is likely to be invalid or unenforceable. |
6 |
(m) The Intellectual Property set forth in Schedule 1.9 of the IP Transfer Agreement includes all pending trademark applications, issued trademark registrations, pending copyright applications, issued copyright registrations, pending patent applications, and issued patents, relating to the Business, that have been applied for by, or issued in the name of, AFBS or Therics, Inc. anywhere in the World. (n) To the Knowledge of AFBS, the use of the trademarks set forth in the Scheduled IP in connection with the respective goods and services specified therein will not conflict with or infringe any Proprietary Rights of any third party. (o) AFBS warrants that, effective as of June 30, 2005 Therics, Inc. changed its corporate name to AFBS, Inc. 2.11 Permits. The Permits listed on Schedule 1.20 of the Transfer Agreement are a true and accurate listing of all approvals, authorizations, registrations and licenses issued by a Governmental Entity required for the Business as of the Closing. 2.12 Inventory. Except for items of Inventory, the value of which does not exceed $50,000 in the aggregate, the Inventory does not include any damaged, obsolete, excessive or outdated goods. 2.13 Product Liability. To the Knowledge of AFBS, AFBS has no liability (and there is no basis for any present or future action against it giving rise to any liability) arising out of any injury to individuals or property as a result of the ownership, possession, or use of any product manufactured, sold, leased, or delivered by AFBS. No product liability or other tort claims have been made or, to the Knowledge of AFBS, threatened against AFBS relating to the products comprising the products sold by the Business in the past five (5) years. To the Knowledge of AFBS, there are no defects in the design or manufacture of products manufactured or sold by AFBS, or any failure by AFBS to warn, test, inspect or instruct of dangers which could form the basis for a product recall (whether or not at the request of a Governmental Entity) or a cause of action for product liability (including, without limitation, failure to warn, test, inspect or instruct) against AFBS. 2.14 No Untrue Statement. To the Knowledge of AFBS, neither this Agreement (including the Schedules and Exhibits hereto) nor any Ancillary Agreement contains any untrue statement of a material fact. ARTICLE III RRT hereby represents and warrants to AFBS at the Closing as follows: 3.1 Organization of TS. TS is a limited liability company duly organized, validly existing and in good standing under the Laws of the State of Ohio and has full limited liability company power and authority to conduct its business as now conducted and to own, use, license and lease its assets and properties as presently conducted. TS is duly qualified to do business |
7 |
and is in good standing as a foreign limited liability company in all jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not have a material adverse effect on TS or its business. 3.2 Authority; Enforceability. This Agreement and the Ancillary Agreements to which RRT is a party, have been executed and delivered by RRT. RRT has full power and capacity to execute and deliver this Agreement and the Ancillary Agreements to which he is a party, to perform his obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. This Agreement and the Ancillary Agreements to which he is a party, are the legal, valid and binding obligations of RRT, enforceable against him in accordance with their respective terms, except as the enforceability thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to the enforcement of creditors’ rights generally and by general principles of equity (whether considered at law or in equity). 3.3 No Violation or Conflict. The execution, delivery and performance by RRT of this Agreement and the Ancillary Agreements to which he is a party, do not and will not (a) conflict with or violate any Law, judgment, order or decree binding on RRT or TS, the articles of organization, the TS Operating Agreement or other organizational documents of TS, or any contract or agreement to which RRT or TS is a party or by which either is bound, provided, however, that the forgoing representation and warranty contained in this sentence shall not relate to compliance with the securities laws or “blue sky” laws of any jurisdiction except the United States of America and the state of Ohio or (b) result in any party to any contract or agreement to which RRT or TS is a party having a right of cancellation or termination thereof or right to exercise any purchase, sale or other option or right thereunder. No notice to or consent or approval of any other Person, and no notice to, filing or registration with, or authorization, consent or approval of, any Governmental Entity is necessary or is required to be made or obtained by RRT or TS in connection with the consummation of the transactions contemplated in this Agreement or the Ancillary Agreements, provided, however, that the forgoing representation and warranty contained in this sentence shall not relate to compliance with the securities laws or “blue sky” laws of any jurisdiction except the United States of America and the state of Ohio. 3.4 No Litigation. Except as set forth on Schedule 3.4, there is no litigation, arbitration proceeding, order, governmental or internal investigation, citation or action of any kind pending or, to the Knowledge of RRT, proposed or threatened, (a) against RRT or TS, (b) relating to the TS Interest, or (c) that seeks restraint, prohibition, damages or other relief in connection with this Agreement or the Ancillary Agreements to which RRT is a party, or the consummation of the transactions contemplated hereby and thereby and, to the Knowledge of RRT, no event has occurred or circumstance exists that may give rise to or serve as a basis for the commencement of any such action. There is no action, suit, proceeding or investigation by TS or RRT currently pending or which TS or RRT intends to initiate. 3.5 Financial Statements. The balance sheets of TS as of December 31, 2004, December 31, 2003 and May 31, 2005, including any notes thereto, which are included in the Financial Statements set forth on Schedule 3.5, are true, complete and correct in all material respects, present fairly the financial condition of TS as of such dates, and were prepared in |
8 |
9 |
(a) With the exception of the patent applications listed on Schedule 3.9, for which an assignment from one or more inventors is still outstanding, TS is the sole and exclusive owner of, or has a valid license to use all of its patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information and other proprietary rights and processes (the “TS Intellectual Property”), free and clear of all Liens. The TS Intellectual Property is identified on Schedule 3.9. (b) To the Knowledge of RRT, no third party is engaging in conduct which conflicts with or infringes in any material way any of such TS intellectual property. To the Knowledge of RRT, the use of the TS intellectual property as currently used does not conflict with or infringe (and the use of the TS Intellectual Property prior to the Closing has not and the use of the TS Intellectual Property will not conflict with or infringe) in any material way any Proprietary Right of any third party, and, except as set forth on Schedule 3.4 and Schedule 3.9, there is no claim, suit, action or proceeding pending or, to the Knowledge of RRT, threatened against TS (i) alleging any such conflict or infringement with any third party’s Proprietary Rights, or (ii) challenging the ownership, use, validity or enforceability of the TS Intellectual Property. (c) With the exception of the license agreements listed on Schedule 3.9, TS has not granted, and, to the Knowledge of RRT, there are not outstanding, any options, licenses or agreements of any kind relating to any of the TS Intellectual Property, nor is TS bound by or a party to any option, license or agreement of any kind with respect to any of the TS Intellectual Property, except as set forth on Schedule 3.9. TS is not obligated to pay any royalties or other payments to third parties with respect to the marketing, sale, distribution, manufacture, license or use of the TS Intellectual Property or any other property or rights, except as set forth on Schedule 3.9. (d) Except as set forth on Schedule 3.9, TS has received and currently holds valid and effective assignments of all inventors’ rights to the inventions covered by the TS Intellectual Property, and no employee, former employee, researcher, former researcher, investigator, former investigator, or any other person may claim rights to any of inventions covered by the TS Intellectual Property. (e) No patent or patent application within the TS Intellectual Property is the subject of any pending interference, opposition, cancellation, protest, reexamination, or other challenge or adversarial proceeding. (f) Except as set forth on Schedule 3.4 and Schedule 3.9, no court orders, judgments, or decrees exist that impair or restrict the use, scope, validity, or enforceability of the TS Intellectual Property, and no action, suit, inquiry, proceeding, or investigation is currently pending or threatened before any court, administrative agency, or other governmental body in which such use, scope, validity, or enforceability is being challenged, either directly or indirectly. |
10 |
(g) To the Knowledge of RRT, no patents in the TS Intellectual Property are invalid or unenforceable, and to the Knowledge of RRT, there are no facts from which it can be inferred that any of the patents in the TS Intellectual Property are invalid or unenforceable. 3.10 No Material Adverse Change. Except as set forth on Schedule 3.10, since December 31, 2004, TS’s business has been operated in the ordinary course and substantially in the same manner as previously conducted, and there has not been any material adverse change in the assets, liabilities, financial condition or results of operations of the business of TS from those reflected in the balance sheet and statements of income of TS as of and for the fiscal year ended December 31, 2004, and, to the Knowledge of RRT, no fact or condition exists or to the Knowledge of RRT is contemplated or threatened that will, or might reasonably be expected to, result in any such material adverse change. (a) RRT has good and valid title to the TS Interest, free and clear of all Liens. The membership interests of TS and the owners thereof immediately prior to the Closing are as set forth on Schedule 3.11. Except as set forth on Schedule 3.11, TS has good and valid title to its properties and assets and good title to its leasehold estates, in each case subject to no Lien, other than (a) those resulting from taxes which have not yet become delinquent, and (b) minor liens and encumbrances which do not materially detract from the value of the property subject thereto or materially impair the operations of TS. The transfer of the TS Interest hereunder complies with the terms of the TS Operating Agreement, and upon the closing of the transactions contemplated herein, AFBS shall become a party to the TS Operating Agreement and a member of TS. All facilities, machinery, equipment, fixtures, vehicles and other properties owned, leased or used by TS are in good operating condition and repair (normal wear and tear excepted) and are reasonably fit for use in accordance with TS’s past practices. TS is in compliance with all material terms of each lease to which it is a party or is otherwise bound. The number of appreciation units issued and outstanding under the TS Appreciation Rights Plans as of the date hereof does not exceed 326,182.87342. (b) The membership interests of TS, immediately following the Closing, are set forth on Schedule 3.11 (except with respect to the appreciation units issued and outstanding under the TS Appreciation Rights Plans). All of the issued and outstanding membership interests of TS are validly issued, fully-paid and nonassessable, and have not been issued in violation of any federal or state securities Laws provided, however, that the forgoing representation and warranty contained in this sentence shall not relate to compliance with the securities laws or “blue sky” laws of any jurisdiction except the United States of America and the state of Ohio. TS does not presently own or control any equity or debt security or other interest in any Person. TS is not a participant in any joint venture, partnership or similar arrangement. (c) Except as set forth in the TS Operating Agreement, no membership interests of TS have been issued subject to a repurchase option, put or buy back agreement on the part of TS. (d) Except as set forth on Schedule 3.11, and except as set forth in the TS Operating Agreement and in the TS Appreciation Rights Plans, there are no outstanding options, |
11 |
12 |
13 |
14 |
and warranties of RRT in Sections 3.1, 3.2, 3.3 and 3.11, shall survive for the applicable statute of limitations period (such period, the “Survival Period”). Except in the event an “Indemnified Party” (as defined below) makes a written claim for indemnification against an “Indemnifying Party” (as defined below) prior to the expiration of the Survival Period, no action or proceeding may be instituted to enforce, or seek damages or other remedies with respect to the breach of, any representation or warranty after such expiration. (a) After the Closing, AFBS and its officers, directors, agents, successors and assigns, as applicable (“AFBS Indemnified Parties”) shall be indemnified and held harmless by Therics for any and all liabilities, losses, damages of any kind, claims, costs, expenses, fines, fees, deficiencies, interest, awards, judgments, amounts paid in settlement and penalties (including, without limitation, attorneys’, consultants’ and experts’ fees and expenses and other costs of defending, investigating or settling claims) actually suffered or incurred by them (including, without limitation, in connection with any action brought or otherwise initiated by any of them) (hereinafter, “Loss(es),” which Loss(es) shall be reduced by the full amount of any insurance collected by the Indemnified Party (or any Affiliate thereof) with respect to such claim or the underlying facts under any applicable policy or policies it being understood that all Indemnified Parties will use good faith efforts to file all insurance claims relating to such Losses), arising out of or resulting from: (i) any inaccuracy in or breach of any representation or warranty of RRT or Therics contained in this Agreement, the Transfer Agreement or the IP Transfer Agreement; (ii) the Post-Closing Liabilities and the Post-Closing IP Liabilities; or (iii) any breach of any covenant or agreement made by RRT or Therics in this Agreement, the Transfer Agreement or the IP Transfer Agreement. (b) After the Closing, Therics and its officers, directors, agents, successors and assigns, as applicable (“Therics Indemnified Parties”), shall be indemnified and held harmless by AFBS for any and all Losses arising out of or resulting from: (i) any inaccuracy in or breach of any representation or warranty of AFBS contained in this Agreement, the Transfer Agreement or the IP Transfer Agreement; (ii) the Retained Liabilities and the Retained IP Liabilities; or (iii) any breach of any covenant or agreement made by AFBS in this Agreement, the Transfer Agreement or the IP Transfer Agreement. (c) Notwithstanding anything to the contrary contained in this Agreement, the maximum aggregate amount of indemnifiable Losses arising out of or resulting from the causes enumerated in Sections 5.2(a)(i) or 5.2(b)(i) that may be recovered from AFBS Indemnified Parties or Therics, as the case may be, shall not exceed (i) in the case of Losses that may be |
15 |
16 |
Xxxxxxx X. Xxxxxx | |
000 Xxxx Xxxxxxxx Xxxx | |
Xxxxx, Xxxx 00000 | |
Facsimile: (000) 000-0000 |
with a copy (which shall not constitute notice) to: |
Xxxxx & Xxxxx Co., L.P.A. | |
Attention: Xxxxx X. Xxxx, Esq. | |
00 Xxxxx Xxxx Xxxxxx, Xxxxx 0000 | |
Xxxxx, Xxxx 00000-0000 | |
Facsimile: (000) 000-0000 |
17 |
If to AFBS: |
AFBS, Inc. | |
c/o Tredegar Corporation | |
Attention: Chief Financial Officer | |
0000 Xxxxxxxx Xxxxxxx | |
Xxxxxxxx, Xxxxxxxx 00000 | |
Facsimile: (000) 000-0000 |
with a copy (which shall not constitute notice) to: |
Hunton & Xxxxxxxx LLP | |
Riverfront Plaza, East Tower | |
000 Xxxx Xxxx Xxxxxx | |
Xxxxxxxx, Xxxxxxxx 00000 | |
Facsimile No.: (000) 000-0000 | |
Attn: X. Xxxxxx Xxxxxxx, III, Esq. and | |
R. Xxxxx Xxxxxx, Xx., Esq. |
18 |
6.5 Third-Party Beneficiaries. Except as expressly provided herein, the terms and provisions of this Agreement are intended solely for the benefit of each party hereto and their respective successors or permitted assigns, and it is not the intention of the parties to confer third-party beneficiary rights, and this Agreement does not confer any such rights, upon any other Person other than any Person entitled to indemnity under Article V. 6.6 No Assignment; Binding Effect. Neither this Agreement nor any right, interest or obligation hereunder may be assigned by any party without the prior written consent of the other party and any attempt to do so will be void. Subject to the preceding sentence, this Agreement is binding upon, inures to the benefit of and is enforceable by the parties hereto and their respective successors and assigns. 6.7 Headings. The headings and table of contents used in this Agreement have been inserted for convenience of reference only and do not define or limit the provisions hereof. 6.8 Invalid Provisions. If any provision of this Agreement is held to be illegal, invalid or unenforceable under any present or future Law, and if the rights or obligations of any party hereto under this Agreement will not be materially and adversely affected thereby, (a) such provision will be fully severable, (b) this Agreement will be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a part hereof, (c) the remaining provisions of this Agreement will remain in full force and effect and will not be affected by the illegal, invalid or unenforceable provision or by its severance herefrom and (d) in lieu of such illegal, invalid or unenforceable provision, there will be added automatically as a part of this Agreement a legal, valid and enforceable provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible. This Agreement, any Ancillary Agreements and any other closing documents shall be governed by and construed in accordance with the laws of the State of Ohio as applied to contracts entered into by Ohio residents and performed entirely in Ohio, without giving effect to its principles or rules regarding conflicts of laws, other than such principles directing application of the laws of Ohio. 6.10 WAIVER OF TRIAL BY JURY. IN ANY ACTION OR PROCEEDING ARISING HEREFROM, THE PARTIES HERETO CONSENT TO TRIAL WITHOUT A JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY PARTY HERETO AGAINST THE OTHER OR THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE FORM OF ACTION OR PROCEEDING. 6.11 Construction. The parties hereto agree that this Agreement is the product of negotiation between sophisticated parties and individuals, all of whom were represented by counsel, and each of whom had an opportunity to participate in and did participate in, the drafting of each provision hereof. Accordingly, ambiguities in this Agreement, if any, shall not be construed strictly or in favor of or against any party hereto, but rather shall be given a fair and reasonable construction without regard to the rule of contra proferentem. |
19 |
6.12 Counterparts. This Agreement may be executed in any number of counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. 6.13 Specific Performance. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity. Nothing in Article V shall be construed or interpreted to limit this Section 6.13. 7.1 Definitions. As used in this Agreement, the following defined terms shall have the meanings indicated below: “AFBS” shall have the meaning set forth in the Preamble of this Agreement. “AFBS Indemnified Parties” shall have the meaning set forth in Section 5.2(a) “AFBS-Related Party” shall mean any “Affiliate” of AFBS or any predecessor in interest to AFBS (including but not limited to Therics, Inc.). “Affiliate” means, as applied to any Person, any other Person directly or indirectly controlling, controlled by or under common control with, that Person. For the purposes of this definition, “control” (including with correlative meanings, the terms “controlling”, “controlled by”, and “under common control with”) as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through ownership of voting securities or by contract or otherwise. “Agreement” means this Unit Purchase Agreement, including (unless the context otherwise requires) the Exhibits, the Schedules and the certificates and instruments delivered in connection herewith, or incorporated by reference, as the same may be amended or supplemented from time to time in accordance with the terms hereof. “Ancillary Agreements” shall mean, collectively, (a) the Transfer Agreement, (b) the IP Transfer Agreement, (c) the Operating Agreement, (d) the TS Operating Agreement, (e) the Sublease, and (f) the Payment Agreement. “Adjusted Annual License Maintenance Fee” means the reduced annual license maintenance fee of $40,000 due on June 30, 2005 set forth in that certain Patent License Agreement, dated as of June 1, 1994, by and between the Massachusetts Institute of Technology and Therics, Inc., as amended by the First through Eight Amendments thereto. “Assumed Contracts” shall have the meaning set forth in the Transfer Agreement. |
20 |
“Assumed IP Contracts” shall have the meaning set forth in the IP Transfer Agreement. “Assumed IP Liabilities” shall have the meaning set forth in the IP Transfer Agreement. “Business” shall mean the business and operations of AFBS as operated and conducted prior to and up through the Effective Time. “Closing” shall have the meaning set forth in Section 1.2(a). “Closing Date” shall have the meaning set forth in Section 1.2(a). “Consents” shall have the meaning set forth in the Transfer Agreement. “Contributed Assets” shall have the meaning set forth in the Transfer Agreement. “Distribution Agreement” shall have the meaning set forth in the Recitals of this Agreement. “Effective Time” shall mean 11:58 p.m. (Eastern Daylight Time) on the Closing Date. “Equipment” shall have the meaning set forth in the Transfer Agreement. “Employees” shall have the meaning set forth in Section 4.4. “Financial Statements” shall mean the unaudited balance sheets and statements of income of TS as of and for the fiscal years ended December 31, 2003 and 2004 and as of and for the five months ended May 31, 2005, including the notes thereto (for 2003 and 2004), which are set forth on Schedule 3.5. “GAAP” means generally accepted accounting principles in the United States, as in effect from time to time. “Great Plains Software” shall mean any of the software identified in Items 86 through 92 on Schedule 1.14 of the Transfer Agreement. “Governmental Entity” shall have the meaning set forth in the Transfer Agreement. “Indemnified Party” shall have the meaning set forth in Section 5.3(a). “Indemnifying Party” shall have the meaning set forth in Section 5.2(d). “Intellectual Property” shall have the meaning set forth in the IP Transfer Agreement. |
21 |
“Internal Revenue Code” means the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder. “Inventory” shall have the meaning set forth in the Transfer Agreement. “IP Assets” shall have the meaning set forth in the IP Transfer Agreement. “IP Consents” shall have the meaning set forth in the IP Transfer Agreement. “IP Transfer Agreement” shall have the meaning set forth in the Recitals of this Agreement. “Knowledge of RRT” shall mean the actual knowledge of Xxxxxxx X. Xxxxxx. “Knowledge of AFBS” shall mean the actual knowledge of Xxxxxx X. Xxxxxxxxx, Xxxxx X. Xxxxxxx, or Xxxx X. Xxxxx. “Law” or “Laws” shall have the meaning set forth in the Transfer Agreement. “Liens” shall have the meaning set forth in the Transfer Agreement. “Loss(es)” shall have the meaning set forth in Section 5.2(a) “Operating Agreement” shall have the meaning set forth in the Recitals of this Agreement. “Payment Agreement” shall have the meaning set forth in the Recitals of this Agreement. “Permits” shall have the meaning set forth in the Transfer Agreement. “Person” means any natural person, corporation, general partnership, limited partnership, limited liability company or partnership, proprietorship, other business organization, trust, union, association or Governmental Entity. “Post-Closing Liabilities” shall have the meaning set forth in the Transfer Agreement. “Post-Closing IP Liabilities” shall have the meaning set forth in the IP Transfer Agreement. “Proprietary Rights” means the legal rights, property rights, and other interests evidenced by or embodied in (1) any idea, design, concept, technique, invention, discovery, or improvement, regardless of patentability, but including patents, patent applications, trade secrets, and know-how; (2) any work of authorship, regardless of copyrightability, but including copyrights and any moral rights recognized by law; (3) any brand name, logo, trade dress, designation of source, trademark, service xxxx, or trade name; and (4) any other similar rights, in each case on a worldwide basis. |
22 |
“Purchased Units” shall have the meaning set forth in the Recitals of this Agreement. “Retained IP Liabilities” shall have the meaning set forth in the IP Transfer Agreement. “Retained Liabilities” shall have the meaning set forth in the Transfer Agreement. “RRT” shall have the meaning set forth in the Preamble of this Agreement. “Scheduled IP” shall have the meaning provided in the IP Transfer Agreement. “Sublease” shall have the meaning set forth in the Recitals of this Agreement. “Survival Period” shall have the meaning set forth in Section 5.1 “Tax” or “Taxes” shall have the meaning provided in the Transfer Agreement. “Tax Returns” means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof. “Therics” shall have the meaning set forth in the Preamble of this Agreement. “Therics Indemnified Party” shall have the meaning set forth in Section 5.2(b) “Third-Party Claims” shall have the meaning set forth in Section 5.3(a) “Transfer Agreement” shall have the meaning set forth in the Recitals of this Agreement. “TS” shall have meaning set forth in the Recitals of this Agreement. “TS Appreciation Rights Plans” means the following: (i) the TS Appreciation Rights Plan dated December 31, 2003; (ii) the TS Appreciation Rights Plan for Employees and Distributors dated January 1, 2005; and (iii) the TS Appreciation Rights Plan for Consultants dated January 1, 2005, as amended March 11, 2005. “TS Intellectual Property” shall have meaning set forth in Section 3.9. “TS Interest” shall have the meaning set forth in the Recitals of this Agreement. “TS Operating Agreement” shall mean the Amended and Restated Operating Agreement of TS, dated as of December 20, 2004, as the same is modified and amended by the following: (i) a certain Addendum to Certain Agreements for Theken Spine, LLC effective December 20, 2004; (ii) a certain Addendum #2 to Certain Agreements for Theken Spine, LLC effective December 20, 2004; (iii) a certain Amendment to Addendum #2 to Certain Agreements for Theken Spine, LLC effective December 20, 2004; and (iv) a certain Amendment to the Theken Spine, LLC Amended and Restated Operating Agreement dated April 1, 2005. |
23 |
Unless the context of this Agreement otherwise requires, (i) words of any gender include each other gender and the neuter, (ii) words using the singular or plural number also include the plural or singular number, respectively, (iii) the terms “hereof,” “herein,” “hereby” and derivative or similar words refer to this entire Agreement as a whole and not to any particular Article, Section or other subdivision, (iv) the terms “Article” or “Section” or other subdivision refer to the specified Article, Section or other subdivision of the body of this Agreement, (v) the words “include,” “includes” and “including” shall be deemed to be followed by the phrase “without limitation,” and (vi) when a reference is made in this Agreement to Schedules or Exhibits, such reference shall be to a Schedule or an Exhibit to this Agreement unless otherwise indicated. All accounting terms used herein and not expressly defined herein shall have the meanings given to them under GAAP. [SIGNATURE PAGES FOLLOW] |
24 |
IN WITNESS WHEREOF, AFBS, Therics and RRT, have caused this Agreement to be signed as of the date first
written above. |
AFBS, INC. | ||
By: | /s/ X. Xxxxxxxxxxx Surgner, Jr. | |
X. Xxxxxxxxxxx Surgner, Jr. Vice President |
||
THERICS, LLC | ||
By: Theken Orthopaedic Inc. | ||
Its: Manager | ||
By: | /s/ Xxxxxxx X. Xxxxxx | |
Xxxxxxx X. Xxxxxx President |
||
/s/ Xxxxxxx X. Xxxxxx | ||
XXXXXXX X. XXXXXX |